Colgate-Palmolive Company $CL Stock Holdings Lessened by Public Sector Pension Investment Board

Public Sector Pension Investment Board cut its position in Colgate-Palmolive Company (NYSE:CL) by 90.2% during the 3rd quarter, HoldingsChannel reports. The firm owned 74,824 shares of the company’s stock after selling 689,758 shares during the quarter. Public Sector Pension Investment Board’s holdings in Colgate-Palmolive were worth $5,981,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently made changes to their positions in CL. Tiemann Investment Advisors LLC boosted its position in shares of Colgate-Palmolive by 2.1% in the 2nd quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after purchasing an additional 125 shares during the period. Westside Investment Management Inc. increased its position in Colgate-Palmolive by 85.5% during the second quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after acquiring an additional 130 shares during the period. S.A. Mason LLC raised its stake in shares of Colgate-Palmolive by 3.9% in the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock valued at $280,000 after purchasing an additional 130 shares in the last quarter. Security National Bank of Sioux City Iowa IA grew its stake in shares of Colgate-Palmolive by 0.8% in the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock valued at $1,298,000 after purchasing an additional 130 shares during the period. Finally, Stratos Wealth Advisors LLC grew its stake in Colgate-Palmolive by 4.5% during the third quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after buying an additional 130 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.1%

Shares of CL stock opened at $95.52 on Thursday. The stock’s fifty day simple moving average is $84.94 and its 200 day simple moving average is $82.11. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90. The firm has a market capitalization of $77.00 billion, a P/E ratio of 36.46, a P/E/G ratio of 4.31 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $0.91 EPS. As a group, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 79.39%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the sale, the insider directly owned 13,751 shares in the company, valued at approximately $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider John Hazlin sold 20,989 shares of the stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares in the company, valued at approximately $1,663,041.25. The trade was a 54.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 184,683 shares of company stock worth $17,486,693. 0.34% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on CL. Wells Fargo & Company boosted their target price on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Sunday, February 1st. Deutsche Bank Aktiengesellschaft increased their price objective on Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Bank of America raised their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. Jefferies Financial Group raised their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and issued a $94.00 target price on shares of Colgate-Palmolive in a research report on Saturday, January 31st. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $94.38.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.